Shareholders of Hungarian drugs producer Egis approved every proposal of the Board of Directors at the company’s annual general meeting on Wednesday. This means shareholders will be entitled to a HUF 120 dividend per share, which corresponds to a 0.7% dividend yield.
The AGM of Shareholders authorized the Company to pay, by debiting the profit, a dividend of HUF 934 million equalling 12% of the registered capital, HUF 120 per share.
Additionally, the AGM re-elected Dr Jean-Philippe Seta, Christian Bazantay, Nicolas Bouts, Ange Diaz, Mrs Gál Péterné, Dr István Hodász, Yves Langourieux, Olivier Laureau, Csaba Poroszlai, Dr József Veress and Zsolt Fehérdi as member to the Board of Directors for the period closing up with the ordinary AGM pertaining to the financial year of 2013/2014.
Charting is displayed using TradingView's technology, a platform, where you can build advanced charts,
spot upcoming trends in the stock screener, and find inspiration in multiple trading ideas